Abstract:Background: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women. Although its cardinal manifestations include hyperandrogenism, oligo/anovulation, and/or polycystic ovarian morphology, PCOS women often display also notable metabolic comorbidities. An array of pathogenic mechanisms have been implicated in the etiology of this heterogeneous endocrine disorder; hyperandrogenism at various developmental periods is proposed as a major driver of the metabolic and reproductive perturbations associated with PCOS. However, the current understanding of the pathophysiology of PCOS-associated metabolic disease is incomplete, and therapeutic strategies used to manage this syndrome's metabolic complications remain limited. Scope of review: This study is a systematic review of the potential etiopathogenic mechanisms of metabolic dysfunction frequently associated with PCOS, with special emphasis on the metabolic impact of androgen excess on different metabolic tissues and the brain. We also briefly summarize the therapeutic approaches currently available to manage metabolic perturbations linked to PCOS, highlighting current weaknesses and future directions. Major conclusions: Androgen excess plays a prominent role in the development of metabolic disturbances associated with PCOS, with a discernible impact on key peripheral metabolic tissues, including the adipose, liver, pancreas, and muscle, and very prominently the brain, contributing to the constellation of metabolic complications of PCOS, from obesity to insulin resistance. However, the current understanding of the pathogenic roles of hyperandrogenism in metabolic dysfunction of PCOS and the underlying mechanisms remain largely incomplete. In addition, the development of more efficient, even personalized therapeutic strategies for the metabolic management of PCOS patients persists as an unmet need that will certainly benefit from a better comprehension of the molecular basis of this heterogeneous syndrome.

The interplay between oxidative stress, zinc, and metabolic dysfunction in polycystic ovarian syndrome

Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.

Evaluation of Oxytocin Level and Its Relationship With Oxidant-Antioxidant Status in Women With Polycystic Ovarian Syndrome

Polycystic ovary syndrome and its management: In view of oxidative stress

Oxidative Stress and Low-Grade Inflammation in Polycystic Ovary Syndrome: Controversies and New Insights

Polycystic Ovary Syndrome and Oxidative Stress. Natural Treatments

Oxidative stress and mitochondrial dysfunction of granulosa cells in polycystic ovarian syndrome

Role of Oxidative Stress in Obese and Nonobese PCOS Patients

Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies

Mechanisms and Target Parameters in Relation to Polycystic Ovary Syndrome and Physical Exercise: Focus on the Master Triad of Hormonal Changes, Oxidative Stress, and Inflammation

The Role Played by Mitochondria in Polycystic Ovary Syndrome

Evaluation of antioxidant defense markers in relation to hormonal and insulin parameters in women with polycystic ovary syndrome (PCOS): A case-control study

Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome

A Molecular and Cellular Review of the Literature

A review of metabolic and microbial influences on women with polycystic ovarian syndrome

Relationship between Serum Levels of Oxidative Stress Markers and Metabolic Syndrome Components in PCOS Women

The potential role of uric acid in women with polycystic ovary syndrome

Endoplasmic Reticulum Stress: A New Research Direction for Polycystic Ovary Syndrome?